ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Name: ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

aggressive b-cell non-hodgkin lymphoma, ann arbor stage iii grade 2 follicular lymphoma, ann arbor stage iii grade 3 follicular lymphoma, ann arbor stage iii marginal zone lymphoma, ann arbor stage iv grade 1 follicular lymphoma, ann arbor stage iv grade 2 follicular lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 160340
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.